Using genetics and smartphone data to predict and prevent repeat suicide attempts
Official title: Prevention of Suicidal Behavior Through Therapeutic Interventions Guided by Digital Phenotype and Pharmacogenetics: The SMARTomicS Study Protocol
Run by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · NCT07422090 · Data updated 2026-11-12
This project will try to combine genetic tests and people’s digital behavior to predict which individuals with a past suicide attempt may be at higher risk of trying again.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz Academic / other |
| Locations | 1 site (Madrid, Madrid) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | January 2028 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT07422090 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 12 and older with at least one prior suicide attempt who can provide a genetic sample and give informed consent (parental consent required for ages 12–17) are the ideal candidates.
✕Probably not a fit
Those who cannot provide a blood/genetic sample or who do not consent to digital data extraction are unlikely to benefit from participation or from the predictive results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective, multi-site observational cohort that will merge genomic and metabolic profiling with digital phenotyping and clinical records in people with a lifetime history of suicide attempt. Participants (age 12 and up, with parental consent for minors) will be recruited from outpatient mental health clinics, emergency departments, and short-stay hospital units and will provide genetic samples plus consent for extraction of digital data such as Google Takeout. Investigators will link omics, prescription changes, electronic health record data, and standardized suicide-rating scales (e.g., C-SSRS) to develop predictive algorithms for suicidal behavior. Data quality checks and representativeness will be performed using hospital records and national statistics.
Why it matters
Potential benefit: If successful, this approach could help clinicians identify people at higher risk of repeat suicidal behavior earlier and tailor treatments using genetic and digital signal information.
How similar studies have gone: Prior work has found some promising genetic and digital signals related to suicide risk, but fully integrated predictive models combining omics and detailed digital phenotypes remain largely experimental.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. At least one suicide attempt in their lifetime. 2. The attempt must have occurred when the participant was older than 12 years old. 3. Participants must be at least 18 years old or have parental consent if aged 12-17. Exclusion Criteria: * medical contraindication prevents blood sample collection * unable to provide informed consent to participate in the study
Where it's running
-
Instituto Fundación Jiménez Díaz
Madrid, Madrid, Spain Recruiting
Study contacts
- Study coordinator: Enrique Baca Garcia, Psychiatrist
- Email: ebaca@fjd.es
- Phone: +34 626932936
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk
This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.
-
New Generation Therapies for Suicide: Refining Brief Cognitive Behavioral Therapy
This study tests different sequences and doses of Brief Cognitive Behavioral Therapy to see if it better reduces suicide risk in adults with recent suicidal thoughts or behavior.
-
Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts in Swedish Psychiatric Inpatient Care
This study tests whether four brief CBT sessions can be delivered during a psychiatric hospital stay to help adults who recently attempted suicide or are at high risk see if the treatment works and is easy to use in routine care.
-
Safety Planning Intervention rollout in Swedish psychiatric services to prevent suicide
This project will try a single-session Safety Planning Intervention with adults who present to psychiatric emergency or inpatient units with suicidal thoughts or attempts to see if it reduces suicide-related emergency visits and hospitalizations.
-
Remote case management to prevent suicide after psychiatric hospital discharge
This project will test whether a 6-month remote program called Pathfinding helps active-duty Army soldiers reduce suicidal behavior after leaving inpatient psychiatric care.
-
Text reminders to help parents keep teens safe after a suicide-related ED visit
This study tests whether sending parents text messages can help them reduce their teen’s access to lethal means and increase safety practices after a suicide-related emergency visit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.